======= PHC1 =======
== Gene Information ==
* **Official Symbol**: PHC1
* **Official Name**: polyhomeotic homolog 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1911|1911]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P78364|P78364]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=PHC1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PHC1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/602978|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene is a homolog of the Drosophila polyhomeotic gene, which is a member of the Polycomb group of genes. The gene product is a component of a multimeric protein complex that contains EDR2 and the vertebrate Polycomb protein BMH1. The gene product, the EDR2 protein, and the Drosophila polyhomeotic protein share 2 highly conserved domains, named homology domains I and II. These domains are involved in protein-protein interactions and may mediate heterodimerization of the protein encoded by this gene and the EDR2 protein. [provided by RefSeq, Jul 2008].
* **UniProt Summary**: Component of a Polycomb group (PcG) multiprotein PRC1- like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility. Required for proper control of cellular levels of GMNN expression. {ECO:0000269|PubMed:23418308}.
|SAM 1|
|SAM 2|
|PRC1 complex|
|PcG protein complex|
|negative regulation of G0 to G1 transition|
|histone ubiquitination|
|regulation of G0 to G1 transition|
|negative regulation of cell cycle process|
|histone modification|
|covalent chromatin modification|
|negative regulation of cell cycle|
|protein ubiquitination|
|chromatin organization|
|regulation of cell cycle process|
|protein modification by small protein conjugation|
|zinc ion binding|
|protein modification by small protein conjugation or removal|
|chromosome organization|
|regulation of cell cycle|
|DNA binding|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp301|VER-155008 3.9μM R06 exp301]]|-1.97|
|[[:results:exp59|UMK57 1μM R01 exp59]]|-1.84|
|[[:results:exp271|CCT251545 0.2μM R06 exp271]]|-1.75|
|[[:results:exp147|Resveratrol 16μM R03 exp147]]|-1.73|
|[[:results:exp456|Benzoate 20000μM R08 exp456]]|1.94|
|[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|2.65|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 18865
* **Expression level (log2 read counts)**: 5.95
{{:chemogenomics:nalm6 dist.png?nolink |}}